ProfileGDS4718 / 225168_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 51% 56% 76% 53% 53% 62% 59% 55% 57% 55% 49% 53% 58% 57% 55% 57% 60% 58% 60% 74% 55% 56% 50% 55% 53% 60% 58% 58% 51% 65% 59% 62% 55% 49% 62% 66% 51% 55% 53% 82% 57% 60% 67% 58% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]5.5783251
GSM549102patient 115, normal, homogenized [OPG study]5.8837756
GSM549104patient 119, normal, homogenized [OPG study]7.5250676
GSM549108patient 138, normal, homogenized [OPG study]5.7040553
GSM549119patient 077, normal, homogenized [OPG study]5.6922453
GSM549133patient 032, cancer, homogenized [OPG study]6.2283962
GSM549139patient 042, cancer, homogenized [OPG study]6.0282159
GSM549099patient 107, normal, homogenized [OPG study]5.7931655
GSM549109patient 139, normal, homogenized [OPG study]5.9676257
GSM549110patient 046, normal, homogenized [OPG study]5.8188255
GSM549114patient 063, normal, homogenized [OPG study]5.3893249
GSM549122patient 082, normal, homogenized [OPG study]5.7253353
GSM549134patient 033, cancer, homogenized [OPG study]6.0045758
GSM549136patient 036, cancer, homogenized [OPG study]5.8823957
GSM549140patient 044, cancer, homogenized [OPG study]5.7934755
GSM549111patient 047, normal, homogenized [OPG study]5.9252157
GSM549113patient 057, normal, homogenized [OPG study]6.1017960
GSM549132patient 031, cancer, homogenized [OPG study]5.9857458
GSM549137patient 038, cancer, homogenized [OPG study]6.1012360
GSM549142patient 047, cancer, homogenized [OPG study]7.142374
GSM549100patient 110, normal, homogenized [OPG study]5.8277855
GSM549107patient 135, normal, homogenized [OPG study]5.828256
GSM549115patient 068, normal, homogenized [OPG study]5.4645250
GSM549116patient 072, normal, homogenized [OPG study]5.7738555
GSM549120patient 078, normal, homogenized [OPG study]5.7018553
GSM549131patient 030, cancer, homogenized [OPG study]6.0811960
GSM549118patient 074, normal, homogenized [OPG study]6.0067558
GSM549129patient 027, cancer, homogenized [OPG study]6.0373558
GSM549123patient 088, normal, homogenized [OPG study]5.561951
GSM549124patient 006, cancer, homogenized [OPG study]6.4714565
GSM549126patient 015, cancer, homogenized [OPG study]6.0751859
GSM549128patient 025, cancer, homogenized [OPG study]6.3278762
GSM549103patient 117, normal, homogenized [OPG study]5.8396355
GSM549117patient 073, normal, homogenized [OPG study]5.3991449
GSM549138patient 041, cancer, homogenized [OPG study]6.2700462
GSM549141patient 045, cancer, homogenized [OPG study]6.6000466
GSM549130patient 028, cancer, homogenized [OPG study]5.5428951
GSM549101patient 111, normal, homogenized [OPG study]5.8526355
GSM549105patient 128, normal, homogenized [OPG study]5.6822153
GSM549106patient 134, normal, homogenized [OPG study]8.2752582
GSM549112patient 048, normal, homogenized [OPG study]5.9010557
GSM549125patient 011, cancer, homogenized [OPG study]6.1165660
GSM549127patient 024, cancer, homogenized [OPG study]6.7344467
GSM549135patient 035, cancer, homogenized [OPG study]5.9944158